We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+7.89%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$314B
AUM Growth
+$19.1B
(+6.5%)
Cap. Flow
+$92.3M
Cap. Flow
% of AUM
0.03%
Top 10 Holdings %
Top 10 Hldgs %
20.84%
Holding
3,440
New
118
Increased
1,247
Reduced
1,874
Closed
82
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$905M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$585M |
| 3 |
Cisco
CSCO
|
+$554M |
| 4 |
International Flavors & Fragrances
IFF
|
+$456M |
| 5 |
Mastercard
MA
|
+$392M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.37B |
| 2 |
DuPont de Nemours
DD
|
+$556M |
| 3 |
Qualcomm
QCOM
|
+$405M |
| 4 |
Merck
MRK
|
+$333M |
| 5 |
TSMC
TSM
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.31% |
| 2 | Consumer Discretionary | 12.98% |
| 3 | Financials | 12.81% |
| 4 | Healthcare | 12.54% |
| 5 | Communication Services | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
MYR Group
MYRG
$5.25B
| $13.2M | ﹤0.01% |
184,227
+1,389
| +0.8% | +$87.9K |
|
1602
Kontoor Brands
KTB
$4.26B
| $13.1M | ﹤0.01% |
270,046
+2,486
| +0.9% | +$111K |
|
1603
AngioDynamics
ANGO
$649M
| $13.1M | ﹤0.01% |
559,944
-3,996
| -0.7% | -$80.8K |
|
1604
Fulton Financial
FULT
$4.64B
| $13.1M | ﹤0.01% |
768,985
-5,568
| -0.7% | -$86.2K |
|
1605
CRISPR Therapeutics
CRSP
$5.17B
| $13.1M | ﹤0.01% |
107,390
+90
| +0.1% | +$13.6K |
|
1606
MillerKnoll
MLKN
$1.67B
| $13.1M | ﹤0.01% |
317,878
+5,815
| +2% | +$223K |
|
1607
Perdoceo Education
PRDO
$2.12B
| $13.1M | ﹤0.01% |
1,093,077
-33,614
| -3% | -$425K |
|
1608
MSC Industrial Direct
MSM
$6.86B
| $13.1M | ﹤0.01% |
144,944
-5,616
| -4% | -$478K |
|
|
HSKA
1609
DELISTED
Heska Corp
HSKA
| $13.1M | ﹤0.01% |
77,516
+17,059
| +28% | +$3.03M |
|
1610
Codexis
CDXS
$158M
| $13.1M | ﹤0.01% |
570,138
+322,793
| +131% | +$7.55M |
|
|
CYBR
1611
DELISTED
CyberArk
CYBR
| $13M | ﹤0.01% |
100,449
+25,675
| +34% | +$3.89M |
|
1612
Eagle Materials
EXP
$6.57B
| $13M | ﹤0.01% |
96,626
-2,699
| -3% | -$327K |
|
1613
Adeia
ADEA
$3.11B
| $13M | ﹤0.01% |
2,253,190
-20,404
| -0.9% | -$118K |
|
1614
LGI Homes
LGIH
$1.4B
| $12.9M | ﹤0.01% |
86,416
-936
| -1% | -$112K |
|
|
BBT
1615
Beacon Financial Corp
BBT
$2.66B
| $12.9M | ﹤0.01% |
577,461
+33,688
| +6% | +$688K |
|
1616
MacroGenics
MGNX
$257M
| $12.9M | ﹤0.01% |
403,503
-469,718
| -54% | -$11.4M |
|
1617
Dorman Products
DORM
$4.18B
| $12.8M | ﹤0.01% |
125,077
+144
| +0.1% | +$14.4K |
|
|
RETA
1618
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $12.8M | ﹤0.01% |
128,506
+2,001
| +2% | +$233K |
|
1619
Renasant Corp
RNST
$3.91B
| $12.8M | ﹤0.01% |
308,709
-516,435
| -63% | -$20.5M |
|
1620
Unity
U
$18.9B
| $12.8M | ﹤0.01% |
127,289
-1,126
| -0.9% | -$139K |
|
|
NXGN
1621
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $12.8M | ﹤0.01% |
705,374
-48,959
| -6% | -$966K |
|
|
RVNC
1622
DELISTED
Revance Therapeutics, Inc.
RVNC
| $12.8M | ﹤0.01% |
456,323
-19,826
| -4% | -$548K |
|
|
GRA
1623
DELISTED
W.R. Grace & Co.
GRA
| $12.7M | ﹤0.01% |
212,776
-584,416
| -73% | -$34.9M |
|
|
FLOW
1624
DELISTED
SPX FLOW, Inc.
FLOW
| $12.7M | ﹤0.01% |
200,103
-3,560
| -2% | -$216K |
|
|
AVNS
1625
DELISTED
Avanos Medical
AVNS
| $12.7M | ﹤0.01% |
289,614
+59,263
| +26% | +$2.78M |
|
Similar funds
VFT
Nuveen's Q1 2021 Portfolio in Review
As of Q1 2021, Nuveen held 3,440 positions worth $314B, up 6.5% from $295B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Nuveen's Q1 2021 filing shows 118 new, 1,247 increased, 1,874 reduced and 82 closed positions. Its largest new stake was Coupang: 6,313,287 shares worth $312M. The largest sale was Apple, an estimated $1.37B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Financials.
- Nuveen's largest Q1 2021 buy was Coupang: 6,313,287 shares worth $312M.
- Nuveen added most to Intel in Q1 2021, an estimated $905M increase.
- Nuveen's biggest Q1 2021 reduction was Apple, cutting an estimated $1.37B.
- Nuveen fully exited PARSLEY ENERGY INC in Q1 2021, selling an estimated $122M.
- Nuveen's ten largest holdings make up 21% of its $314B portfolio in Q1 2021.
- Nuveen opened 118 new positions and closed 82 in Q1 2021.
- Nuveen's portfolio value rose 6.5% quarter-over-quarter to $314B.
Based on Nuveen's 13F filing for Q1 2021, filed 17 May 2021.